Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042Source: DataRank Database

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers is a research paper published in Cell (2025). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 18.89)OA: hybridTopics (52)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (47)

Peter Dutey‐Magni ORCID,Marina Parry ORCID,Larissa Mendes ORCID,Ashwin Sachdeva ORCID,James A. Proudfoot ORCID

Live enrichment

PubMed:40865526 OpenAlex:https://openalex.org/W4413680397

Prostate Cancer Foundation

Grant: 2019CHAL2729

Cancer Research UK

Grant: A22744

Prostate Cancer UK

Grant: MA-ETNA19-009

Prostate Cancer UK

Grant: MA-PM16-001

NCI NIH HHS

Grant: R01 CA238020

National Institutes of Health

Veracyte Inc

National Institute for Health and Care Research

US Department of Defense

UK Research and Innovation Medical Research Council

John Black Charitable Foundation

FWCI

18.89

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://www.cell.com/cell/pdf/S0092-8674(25)00864-5.pdf

publisherhttps://www.cell.com/cell/pdf/S0092-8674(25)00864-5.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867425008645?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867425008645?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2025.07.042

Fields of Study

Prostate Cancer Treatment and ResearchCancer, Lipids, and MetabolismCancer Genomics and DiagnosticsHumansMaleProstatic NeoplasmsDocetaxelTranscriptomePTEN PhosphohydrolaseBiomarkers, TumorAndrostenesPrognosisAgedReceptors, AndrogenAntineoplastic AgentsMiddle AgedTaxoidsGene Expression Regulation, Neoplastic

MeSH Terms

DocetaxelAgedAndrostenesAntineoplastic AgentsHumansMaleMiddle AgedPrognosisProstatic NeoplasmsReceptors, AndrogenBiomarkers, TumorGene Expression Regulation, NeoplasticTaxoidsPTEN PhosphohydrolaseTranscriptome

Keywords

BiologyTranscriptomeProstate cancerProstateSensitivity (control systems)OncologyComputational biologyCancer researchInternal medicineBioinformaticsGene expressionCancerGeneticsGenePTENDocetaxelAbirateroneStampede TrialTranscriptome-wide Expression Classifiers

Sustainable Development Goals

SDG 0: Good health and well-being